Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

[Chronic kidney disease what is it?].

Joly D.

Rev Prat. 2012 Jan;62(1):34-7. French.

PMID:
22335064
2.

[Epidemiology of chronic kidney disease].

Noël D, Landais P.

Rev Prat. 2012 Jan;62(1):38-42. French. Erratum in: Rev Prat. 2012 Feb;62(2):197.

PMID:
22335065
3.

Serum creatinine vs. albuminuria as biomarkers for the estimation of cardiovascular risk.

Kalaitzidis RG, Bakris GL.

Curr Vasc Pharmacol. 2010 Sep;8(5):604-11. Review.

PMID:
20507275
4.

Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease.

De Serres SA, Varghese JC, Levin A.

Curr Opin Nephrol Hypertens. 2012 Nov;21(6):619-27. doi: 10.1097/MNH.0b013e32835846e3. Review.

PMID:
22914685
5.

The case for using albuminuria in staging chronic kidney disease.

Gansevoort RT, de Jong PE.

J Am Soc Nephrol. 2009 Mar;20(3):465-8. doi: 10.1681/ASN.2008111212. Review. No abstract available.

6.

Chronic kidney disease: detection and evaluation.

Baumgarten M, Gehr T.

Am Fam Physician. 2011 Nov 15;84(10):1138-48. Review.

7.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
8.

Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.

Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group.

Nephrol Dial Transplant. 2008 Dec;23(12):3851-8. doi: 10.1093/ndt/gfn356. Epub 2008 Jul 18.

PMID:
18641082
9.

The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease.

van Kuijk JP, Flu WJ, Chonchol M, Welten GM, Verhagen HJ, Bax JJ, Poldermans D.

Nephrol Dial Transplant. 2010 Jun;25(6):1882-8. doi: 10.1093/ndt/gfp756. Epub 2010 Jan 8.

PMID:
20061315
10.

Antioxidants for chronic kidney disease.

Jun M.

Nephrology (Carlton). 2013 Aug;18(8):576-8. doi: 10.1111/nep.12103. Review. No abstract available.

PMID:
23865542
11.

Recommendations for early diagnosis of chronic kidney disease.

Bosan IB.

Ann Afr Med. 2007 Sep;6(3):130-6. Review.

12.

[Chronic renal insufficiency and cardiovascular disease].

Charriere S, Rognant N, Chiche F, Cremer A, Deray G, Priou M.

Ann Cardiol Angeiol (Paris). 2009 Feb;58(1):40-52. doi: 10.1016/j.ancard.2008.07.010. Epub 2008 Aug 19. Review. French.

PMID:
18937921
13.

Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients.

Viazzi F, Leoncini G, Conti N, Tomolillo C, Giachero G, Vercelli M, Deferrari G, Pontremoli R.

J Hypertens. 2010 Apr;28(4):848-55. doi: 10.1097/HJH.0b013e328336ed09.

PMID:
20087212
14.

Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function.

Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D.

Nephrol Dial Transplant. 2005 Jan;20(1):129-34. Epub 2004 Dec 7.

PMID:
15585515
15.

Albuminuria: when urine predicts kidney and cardiovascular disease.

Stephen R, Jolly SE, Nally JV Jr, Navaneethan SD.

Cleve Clin J Med. 2014 Jan;81(1):41-50. doi: 10.3949/ccjm.81a.13040. Review.

16.

[Stage 3-5 chronic kidney disease--what is the real prevalence in Romania?].

Covic A, Schiller A, Constantinescu O, Bredeţean V, Mihăescu A, Olariu N, Seica A, Cepoi V, Gusbeth-Tatomir P.

Rev Med Chir Soc Med Nat Iasi. 2008 Oct-Dec;112(4):922-31. Romanian.

PMID:
20209763
17.

Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT Jr, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber MA, Franklin S, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T; ALLHAT Collaborative Research Group.

Ann Intern Med. 2006 Feb 7;144(3):172-80.

PMID:
16461961
18.

Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.

Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.

Nephrology (Carlton). 2008 Jun;13(3):242-6. doi: 10.1111/j.1440-1797.2007.00898.x. Epub 2008 Jan 23.

PMID:
18221258
19.

Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein.

Donadio C.

Am J Physiol Renal Physiol. 2010 Dec;299(6):F1407-23. doi: 10.1152/ajprenal.00507.2009. Epub 2010 Sep 15.

20.

Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction.

Kato K, Takata Y, Usui Y, Shiina K, Asano K, Hashimura Y, Saruhara H, Nishihata Y, Tomiyama H, Yamashina A.

Respir Med. 2011 Apr;105(4):643-9. doi: 10.1016/j.rmed.2010.11.024. Epub 2010 Dec 22.

Supplemental Content

Support Center